Related Experiment Videos

Analgesic activity of 2-amino-4-methylpyridine, a novel NO synthase inhibitor

E R Pettipher¹, T A Hibbs, M A Smith

¹Central Research Division, Pfizer Inc., Groton, CT 06340, USA.

Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]

|August 1, 1997

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

The preclinical pharmacological profile of the potent and selective leukotriene B4 antagonist CP-195543.

The Journal of pharmacology and experimental therapeutics·1998

The inhibitory effect of rolipram on TNF-alpha production in mouse blood ex vivo is dependent upon the release of corticosterone and adrenaline.

Cytokine·1997

Effect of the inducible nitric oxide synthase inhibitors aminoguanidine and L-N6-(1-iminoethyl)lysine on zymosan-induced plasma extravasation in rat skin.

Journal of immunology (Baltimore, Md. : 1950)·1997

The phosphodiesterase type 4 (PDE4) inhibitor CP-80,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNFalpha) production in mice: effect of adrenalectomy.

The Journal of pharmacology and experimental therapeutics·1997

2-Amino-4-methylpyridine as a potent inhibitor of inducible NO synthase activity in vitro and in vivo.

British journal of pharmacology·1996

Regulation of tumour necrosis factor production by adrenal hormones in vivo: insights into the antiinflammatory activity of rolipram.

British journal of pharmacology·1996

See all related articles